Top Markets
Coin of the day
Welgene Biotech Co.,Ltd. Welgene Biotech Co.,Ltd.

Welgene Biotech Co.,Ltd.

6661
Rangering i aksjer #31673
Welgene Biotech Co.,Ltd. primarily focuses on delivering genetic analysis... Welgene Biotech Co.,Ltd. primarily focuses on delivering genetic analysis services. The company provides comprehensive support for scientific research, employing a range of advanced laboratory techniques such as genetic sequencing, microarray analysis, qPCR verification, nucleic acid extraction and quality control, LCM single cell experimentation, and intricate bioinformatics analysis. A key offering in their portfolio is Cytoscan, an array-based comparative genomic hybridization (CGH) solution. Beyond services, Welgene Biotech also supplies essential laboratory products, including various reagents, consumable items, and specialized instruments, alongside dedicated software solutions. Established in 2003, the company operates from its headquarters in Taipei City, Taiwan.
Aksjekurs
$0.53422367
Markedsverdi
$12.45M
Endring (1 dag)
0.30%
Endring (1 år)
-19.98%
Land
TW
Handel Welgene Biotech Co.,Ltd. (6661)

Kategori

P/B-forhold for Welgene Biotech Co.,Ltd. (6661)
P/B-forhold per 2026 TTM: 0
Ifølge Welgene Biotech Co.,Ltd. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Welgene Biotech Co.,Ltd. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
4.1431 -
US
2.7156 -
US
- -
CN
24.3791 -
US
27.366 -
US